JOHNSON CITY, Tenn., April 13, 2016 /PRNewswire/ — NN, Inc., (NASDAQ: NNBR), a diversified industrial company, announced today that it will attend the BIOMEDevice Conference and Expo in Boston, MA on April 13th-14th, 2016.
The BIOMEDevice Conference and Expo brings together industry thought leaders to discuss the latest medical technologies, advanced manufacturing techniques, new materials, and suppliers from every step in the medical manufacturing process.
NN will be displaying its comprehensive product and process platform that delivers engineered solutions for several end-markets including the medical device industry. Visitors to the NN display, booth 305, will be able to see all of our product capabilities: molded and machined plastics, progressive metal stamping, precision machining, and additive manufacturing. In addition visitors will be able to speak with our technical team about precision components and assemblies that utilize our global technology platform.
Chris Qualters, Vice President and Chief Commercial Officer, commented, “Our engineered solution platform allows us to collaborate with our customers on designs and manufacturing technologies that result in more capable products to improve patient outcomes.” Qualters continued, “We are looking forward to BIOMEDevice as it provides an opportunity for us to work together with new and established partners, fellow engineers, designers, and managers to bring the next big thing in the medical device industry into reality.”
NN, Inc., a diversified industrial company, combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies for a variety of markets on a global basis. Headquartered in Johnson City, Tennessee, NN has 42 manufacturing plants in North America, Western Europe, Eastern Europe, South America and China.
Except for specific historical information, many of the matters discussed in this press release may express or imply projections of revenues or expenditures, statements of plans and objectives or future operations or statements of future economic performance. These, and similar statements, are forward-looking statements concerning matters that involve risks, uncertainties and other factors which may cause the actual performance of NN, Inc. and its subsidiaries to differ materially from those expressed or implied by this discussion. All forward-looking information is provided by the Company pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “assumptions”, “target”, “guidance”, “outlook”, “plans”, “projection”, “may”, “will”, “would”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “potential” or “continue” (or the negative or other derivatives of each of these terms) or similar terminology. Factors which could materially affect actual results include, but are not limited to: general economic conditions and economic conditions in the industrial sector, inventory levels, regulatory compliance costs and the Company’s ability to manage these costs, start-up costs for new operations, debt reduction, competitive influences, risks that current customers will commence or increase captive production, risks of capacity underutilization, quality issues, availability and price of raw materials, currency and other risks associated with international trade, the Company’s dependence on certain major customers, and the successful implementation of the global growth plan including development of new products. Similarly, statements made herein and elsewhere regarding completed acquisitions are also forward-looking statements, including statements relating to the future performance and prospects of an acquired business, the expected benefits of an acquisition on the Company’s future business and operations and the ability of the Company to successfully integrate recently acquired businesses.
For additional information concerning such risk factors and cautionary statements, please see the section titled “Risk Factors” in the Company’s periodic reports filed with the Securities and Exchange Commission, including, but not limited to, the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015. Except as required by law, we undertake no obligation to update or revise any forward-looking statements we make in our press releases, whether as a result of new information, future events or otherwise.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nn-to-attend-biomedevice-conference–expo-300250817.html
SOURCE NN, Inc.
AT THE COMPANY, Robbie Atkinson, VP, Corporate Treasurer & Investor Relations, (423) 434-8398; AT FINANCIAL RELATIONS BOARD, Marilynn Meek, (General info), 212-827-3773